Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2233278rdf:typepubmed:Citationlld:pubmed
pubmed-article:2233278lifeskim:mentionsumls-concept:C0043210lld:lifeskim
pubmed-article:2233278lifeskim:mentionsumls-concept:C0015780lld:lifeskim
pubmed-article:2233278lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:2233278lifeskim:mentionsumls-concept:C0002744lld:lifeskim
pubmed-article:2233278lifeskim:mentionsumls-concept:C0036884lld:lifeskim
pubmed-article:2233278lifeskim:mentionsumls-concept:C0232970lld:lifeskim
pubmed-article:2233278lifeskim:mentionsumls-concept:C2246343lld:lifeskim
pubmed-article:2233278pubmed:issue11lld:pubmed
pubmed-article:2233278pubmed:dateCreated1990-12-4lld:pubmed
pubmed-article:2233278pubmed:abstractTextThe effect of anabolic steroid therapy and estrogen-progestogen substitution therapy on serum concentration of procollagen type III aminoterminal peptide (PIIINP), a measure of collagen synthesis, in postmenopausal women was studied in two double-blind studies: (1) 39 women allocated to treatment with either 50 mg nandrolone decanoate as an intramuscular depot or placebo injections every third week for 1 year, and (2) 40 women allocated to receive either 2 mg 17 beta-estradiol plus 1 mg norethisterone acetate daily or placebo tablets for 1 year. Serum PIIINP was measured every 3 months during the study. Anabolic steroid therapy resulted in a more than 50% increase (P less than .001) in serum PIIINP at 3 months, which thereafter decayed but remained significantly increased throughout the study period. Serum PIIINP showed the same pattern during estrogen-progestogen therapy, but to a lesser degree. We conclude that anabolic steroids stimulate type III collagen synthesis in postmenopausal women, while estrogen-progestogen therapy may have such an effect, but only to a lesser degree.lld:pubmed
pubmed-article:2233278pubmed:languageenglld:pubmed
pubmed-article:2233278pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233278pubmed:citationSubsetIMlld:pubmed
pubmed-article:2233278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233278pubmed:statusMEDLINElld:pubmed
pubmed-article:2233278pubmed:monthNovlld:pubmed
pubmed-article:2233278pubmed:issn0026-0495lld:pubmed
pubmed-article:2233278pubmed:authorpubmed-author:ChristiansenC...lld:pubmed
pubmed-article:2233278pubmed:authorpubmed-author:PødenphantJJlld:pubmed
pubmed-article:2233278pubmed:authorpubmed-author:RiisB JBJlld:pubmed
pubmed-article:2233278pubmed:authorpubmed-author:HassagerCClld:pubmed
pubmed-article:2233278pubmed:authorpubmed-author:JensenL TLTlld:pubmed
pubmed-article:2233278pubmed:issnTypePrintlld:pubmed
pubmed-article:2233278pubmed:volume39lld:pubmed
pubmed-article:2233278pubmed:ownerNLMlld:pubmed
pubmed-article:2233278pubmed:authorsCompleteYlld:pubmed
pubmed-article:2233278pubmed:pagination1167-9lld:pubmed
pubmed-article:2233278pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2233278pubmed:meshHeadingpubmed-meshheading:2233278-...lld:pubmed
pubmed-article:2233278pubmed:meshHeadingpubmed-meshheading:2233278-...lld:pubmed
pubmed-article:2233278pubmed:meshHeadingpubmed-meshheading:2233278-...lld:pubmed
pubmed-article:2233278pubmed:meshHeadingpubmed-meshheading:2233278-...lld:pubmed
pubmed-article:2233278pubmed:meshHeadingpubmed-meshheading:2233278-...lld:pubmed
pubmed-article:2233278pubmed:meshHeadingpubmed-meshheading:2233278-...lld:pubmed
pubmed-article:2233278pubmed:meshHeadingpubmed-meshheading:2233278-...lld:pubmed
pubmed-article:2233278pubmed:meshHeadingpubmed-meshheading:2233278-...lld:pubmed
pubmed-article:2233278pubmed:meshHeadingpubmed-meshheading:2233278-...lld:pubmed
pubmed-article:2233278pubmed:meshHeadingpubmed-meshheading:2233278-...lld:pubmed
pubmed-article:2233278pubmed:meshHeadingpubmed-meshheading:2233278-...lld:pubmed
pubmed-article:2233278pubmed:meshHeadingpubmed-meshheading:2233278-...lld:pubmed
pubmed-article:2233278pubmed:meshHeadingpubmed-meshheading:2233278-...lld:pubmed
pubmed-article:2233278pubmed:year1990lld:pubmed
pubmed-article:2233278pubmed:articleTitleCollagen synthesis in postmenopausal women during therapy with anabolic steroid or female sex hormones.lld:pubmed
pubmed-article:2233278pubmed:affiliationDepartment of Clinical Chemistry, Glostrup Hospital, University of Copenhagen, Denmark.lld:pubmed
pubmed-article:2233278pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2233278pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2233278pubmed:publicationTypeControlled Clinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2233278lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2233278lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2233278lld:pubmed